Physician
Rheumatology
Dr. Ken J. Bulpitt, MD
|
|
Give Review
Ken J. Bulpitt, MD works in the field of Rheumatology. He researched medicine at David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is one of the top medical schools in the US. David Geffen School of Medicine at UCLA is ranked 13/7 in Research/PrimaryCare. He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACR)". Bulpitt has written publications. He has 29 publications published with PubMed. The lastest publication is: 'A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.'
Publications
- The complexity of care for patients with rheumatoid Arthritis: metrics for better understanding chronic disease care.
- Development and evaluation of a patient self-report case-finding method for rheumatoid Arthritis.
- Case finding for population-based studies of rheumatoid Arthritis: comparison of patient self-reported ACR criteria-based algorithms to physician-implicit review for d...
- Etanercept added to background methotrexate therapy in patients with rheumatoid Arthritis: continued observations.
- Relative contributions of the components of the American College of Rheumatology 20% criteria for improvement to responder status in patients with early seropositive r...
- Biologic therapies in rheumatoid Arthritis.
- Direct and indirect costs associated with the onset of seropositive rheumatoid Arthritis. Western Consortium of Practicing Rheumatologists.
- Etanercept therapy in rheumatoid Arthritis. A randomized, controlled trial.
- A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid Arthritis receiving methotrexate.
- Monitoring radiographic changes in early rheumatoid Arthritis.
- CAMPATH-1H in rheumatoid Arthritis--an intravenous dose-ranging study.
- Rheumatoid Arthritis. Outcome measures.
- Early undifferentiated connective tissue Disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis).
- Clinical trials of osteoArthritis therapies.
- DC-ART classification: review of relevant clinical studies.
- CAMPATH-1H, a humanized monoclonal antibody, in refractory rheumatoid Arthritis. An intravenous dose-escalation study.
- Structural and replicative forms of mitochondrial DNA in tissues from adult and senescent BALB/c mice and Fischer 344 rats.
- Variation in the frequency of complex forms of mitochondrial DNA in different brain regions of senescent mice.
- Studies of sequence heterogeneity of mitochondrial DNA from rat and mouse tissues: evidence for an increased frequency of deletions/additions with aging.
- Systemic lupus erythematosus and concurrent cytomegalovirus vasculitis: diagnosis by antemortem skin biopsy.
- Association of L-tryptophan and an illness resembling eosinophilic fasciitis. Clinical and histopathologic findings in four patients with eosinophilia-myalgia Syndrome.
- Neuromuscular manifestations of L-tryptophan-associated eosinophilia-myalgia Syndrome: a histomorphologic analysis of 14 patients.
- Application of explicit process of care measurement to rheumatoid Arthritis: Moving from evidence to practice.
- Dating the "window of therapeutic opportunity" in early rheumatoid Arthritis: accuracy of patient recall of Arthritis symptom onset.
- Correlation of single time-point damage scores with observed progression of radiographic damage during the first 6 years of rheumatoid Arthritis.
- Autoantibodies in early seropositive rheumatoid Arthritis, before and during disease modifying antirheumatic drug treatment.
- Classifying structural joint damage in rheumatoid Arthritis as progressive or nonprogressive using a composite definition of joint radiographic change: a preliminary p...
- Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein, Ro 45-2081 (lenercept): results of a dose-finding study in rheumatoid Arthritis.
Schools
David Geffen School Of Medicine At UCLA University Of California Los Angeles
UCLA Med Center
Procedures Preformed
- Joint Drainage
- Steroid Injection
- Viscosupplementation With Hyaluronate
Conditions Treated
- Arthritis
- Bursitis
- Degenerative Disc Disease
- Dermatomyositis
- View All
Doctors Specialties
- Rheumatology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACR)
Education
-
UCLA Medical Center -
David Geffen School of Medicine at UCLA
Hospital
-
Ronald Reagan UCLA Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1619902764 |
| Last Name Of The Provider | BULPITT |
| First Name Of The Provider | KEN |
| View All |
Similar Doctors
|
|
Dr. Kenneth M. Nies, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William Chin, MD |
|
|
Dr. Dilrukshie Cooray, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George Karpouzas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael D. Duffin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gopika D. Datta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Noreen M. Hussaini, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Madhavi L. Siddhanthi, MD
This Doctor is OpenDoctor Recommended.
|